![]() ![]() Zantac OTC (over the counter) has been around for over a decade and meets all the specified safety requirements for use in the OTC market,” a statement from Sanofi, the maker of Zantac, said. T he uncertainty of the COVID-19 pandemic has made our stomachs churn, and now, evidence suggests that intense heartburn may be linked with worse symptoms of the disease. It’s caused by stomach acid rising into your esophagus (reflux), which runs through your chest, close to your heart. What is heartburn Heartburn is a painful, burning feeling in the middle of your chest. “Sanofi takes patient safety seriously, and we are committed to working with the FDA. Overview Heartburn feels like it's in your heart, but it actually occurs in your esophagus. The FDA said people don’t need to stop taking the medication, but patients taking the prescription versions who wish to discontinue may want to talk to their doctor about other treatment options, and people taking an over-the-counter version can consider other medicines approved for their conditions. Ranitidine is an over-the-counter and prescription histamine-2 blocker, which decreases the amount of acid that the stomach creates. Surprise, everyone’s favorite remedy can help ease heartburn. Try chewing a stick of gum for 30 minutes for decreased heartburn. The FDA will share more information with the public and industry as we learn more throughout the investigation.” Saliva helps dilute acid, so increasing the amount of saliva you produce after a meal is a great way to help prevent acid production. “We do not have any information to share on how many companies’ products could be affected. So far, NDMA has been found in ranitidine in low levels and we are not calling for consumers and patients to stop taking ranitidine at this time,” he said. ![]() “At this time there are no company recalls and FDA is not urging companies to recall. Now, with NDMA being found in samples of ranitidine, “we are still investigating all ranitidine products and we are continuing to test additional samples,” FDA spokesman Jeremy Kahn said in an email on Friday. After valsartan recall, study offers 'modest reassurance' on short-term cancer risk
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |